CoChat

Continuous Positive Airway Pressure Treatment of Mild to Moderate Obstructive Sleep Apnea Reduces Cardiovascular Risk

Buchner, Nikolaus J., Sanner, Bernd M., Borgel, Jan, Rump, Lars C. · 2007 · American Journal of Respiratory and Critical Care Medicine

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Rationale: Obstructive sleep apnea (OSA) is linked to increased cardiovascular risk, but the impact of mild forms of OSA and their treatment on cardiovascular outcomes remains controversial. Objectives: To prospectively investigate cardiovascular outcomes in treated versus untreated patients with OSA. Methods: Consecutive sleep laboratory patients with all degrees of OSA were included. Endpoints were nonfatal (myocardial infarction, stroke, and acute coronary syndrome requiring revascularization procedures) and fatal (death from myocardial infarction or stroke) cardiovascular events. Measurements and Main Results: Comparison of event-free survival rates in treated versus untreated patients (Kaplan-Meier estimates, log-rank test). Of 449 patients enrolled (age, 56.0 ± 10.5 years; body mass index, 30.8 ± 5.4 kg/m2), 364 patients received OSA treatment, and 85 patients remained untreated. Median follow-up was 72.0 months (range, 1–156). Mean apnea–hypopnea index before treatment was 30.9 ± 21.8/hour in treated and 15.3 ± 13.0/hour in untreated patients, but there were no differences in cardiovascular comorbidities or risk factors. In patients with mild–moderate OSA (n = 288), events were more frequent in untreated patients (estimated event-free survival at 10 yr, 51.8 vs. 80.3% [P < 0.001]; absolute risk reduction, 28.5%; number needed to treat to prevent one event/10 yr, 3.5). After adjustment for age, gender, cardiovascular risk factors, and comorbidities at baseline, OSA treatment was an independent predictor for events (hazard ratio, 0.36; 95% confidence interval, 0.21–0.62; P < 0.001). Conclusions: OSA treatment was associated with a cardiovascular risk reduction of 64% independent from age and preexisting cardiovascular comorbidities. OSA treatment should be considered for primary and secondary cardiovascular prevention, even in milder OSA.

Overview

Integrity signals

Registry

Crossref · 10.1164/rccm.200611-1588oc

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Cited by

See all 351

Metadata

Authors
Buchner, N. J., Sanner, B. M., Borgel, J., & Rump, L. C.
Affiliations
  • Universitätsklinik Marien Hospital Herne (DE)
  • Department of Internal Medicine, Bethesda Hospital,Wuppertal, Germany; and
  • Department of Cardiology and Angiology, St. Josef-Hospital/Bergmannsheil, Ruhr University Bochum, Bochum, Germany
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2007-12
Volume
176
Issue
12
Pages
1274-1280
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2103647655
Cited by
317
References
44
Citations by year
2025: 2 · 2024: 6 · 2023: 14 · 2022: 10 · 2021: 13 · 2020: 14 · 2019: 10 · 2018: 13 · 2017: 14 · 2016: 17 · 2015: 15 · 2014: 39 · 2013: 23 · 2012: 19
FWCI
16.92
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
Keywords
obstructive sleep apnea, continuous positive airway pressure, cardiovascular risk, cardiovascular events, myocardial infarction, stroke, acute coronary syndrome, event-free survival, cardiovascular disease prevention
MeSH terms
Adult, Aged, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Sleep Apnea Syndromes, Disease-Free Survival, Continuous Positive Airway Pressure, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.